Content about Specialty Pharmacy

February 24, 2010
Study finds bitter melon may reduce breast cancer risk

Many Westerners trying it for the first time cringe the moment it enters their mouths,...

February 23, 2010
Centric Health Resources supports third annual Rare Disease Day

A nationwide, patient-centered health management organization, serving patients with rare, ultra-orphan disorders, is supporting the...

February 23, 2010
FDA committee recommends approval of Xifaxan

A Food and Drug Administration committee has recommended approval for a drug to treat a...

February 23, 2010
Report projects breast cancer drug sales to exceed $1 billion

An investigational drug for treating breast cancer will garner sales of more than $1 billion...

February 22, 2010
Combined HIV drug therapy may cause heart rhythm issues

Combining two HIV drugs made by Roche subsidiary Genentech and Abbott could cause abnormalities in...

February 22, 2010
Inhaled CF antibiotic receives FDA approval

The Food and Drug Administration has approved the first inhaled antibiotic for cystic fibrosis in...

February 21, 2010
Decision Resources projects Crohn's disease market surge

The high prices of drugs made by Johnson & Johnson and Abbott will drive the...

February 21, 2010
FDA approves Parkinson's disease treatment

The Food and Drug Administration has approved a new treatment for Parkinson’s disease made by...

February 18, 2010
FDA approved more than 50 cancer drugs in two years, study says

The Office of Oncology Drug Products at the Food and Drug Administration approved more than...

February 18, 2010
Novartis' Tasigna receives priority review from FDA

The Food and Drug Administration will shorten its review time of a Novartis drug under...

February 18, 2010
Rituxan gets nod of approval from FDA

The Food and Drug Administration has approved a drug made by Roche subsidiary Genentech and...

February 16, 2010
Drug makers sign agreement to develop rheumatoid arthritis drug

Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...

February 16, 2010
FDA gives orphan-drug designation to treatment for kidney transplant patients

The Food and Drug Administration has given orphan-drug designation to an investigational preventive treatment for...

February 11, 2010
FDA approves new formulation of HIV treatment drug

The Food and Drug Administration has approved a new formulation of an anti-retroviral drug for...

February 10, 2010
AmerisourceBergen partners with AssistMed to improve medication adherence among patients

AmerisourceBergen will use a set of cell phone and Web applications to increase medication adherence...

February 10, 2010
Biodel presents clinical trial results of VIAject at conference

A specialty biopharmaceutical company focused on endocrine disorder treatments will present results of two phase...

February 10, 2010
Decision Resources: Ulcerative colitis drug market could double by 2018

The market for drugs to treat ulcerative colitis could almost double within less than 10...

February 10, 2010
Flu vaccine trial yields positive results, Novavax says

A clinical trial of a seasonal influenza vaccine that began in May 2009 has produced...

February 9, 2010
CARES by GSK aids patients with limited insurance coverage

Patients with limited insurance coverage will have increased access to cancer and specialty drugs under...

February 9, 2010
Novartis to develop, market hepatitis C drug

Novartis has gained exclusive rights to develop and market a hepatitis C drug that is...

February 8, 2010
Amgen's prostate cancer drug more effective than competitor, study concludes

An investigational drug made by Amgen for treating prostate cancer that had spread to the...

February 8, 2010
Takeda to investigate interactions of anti-clotting drugs, PPIs in GERD

A research and development arm of Japanese drug maker Takeda has started a clinical trial...

February 7, 2010
Cornerstone moves drug testing site for investigational cancer treatment

Early- and mid-stage clinical trials of an investigational drug for treating cancer have a new...

February 7, 2010
FDA issues complete response letter for Zuplenz

The Food and Drug Administration has declined to approve a drug made by Strativa Pharmaceuticals...

February 7, 2010
Novavax ends vaccine development talks with ROVI Pharmaceuticals

Negotiations between Novavax and ROVI Pharmaceuticals collapsed after the two companies failed to find common...